Skip to main content

Advertisement

Open Peer Review Reports for: Design and rationale of FOCUS (PX-171-011): A randomized, open-label, phase 3 study of carfilzomib versus best supportive care regimen in patients with relapsed and refractory multiple myeloma (R/R MM)

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
16 Feb 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
8 Jun 2012 Reviewed Reviewer Report - Nikoletta Lendvai
16 Jun 2012 Reviewed Reviewer Report - Craig Hofmeister
6 Jul 2012 Author responded Author comments - Roman Hajek
Resubmission - Version 3
6 Jul 2012 Submitted Manuscript version 3
24 Jul 2012 Author responded Author comments - Roman Hajek
Resubmission - Version 4
24 Jul 2012 Submitted Manuscript version 4
Publishing
31 Jul 2012 Editorially accepted
19 Sep 2012 Article published 10.1186/1471-2407-12-415

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement